Maggie Hassan actually said...

For some medications with serious safety concerns, FDA requires manufacturers to set up risk evaluation and mitigation strategies, otherwise...

And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost.

REMS has really had two problems with, the first one was we as the generics, as we reverse engineer, need the product that we are reverse en...

I support the Honoring Our PACT Act, and I look forward to working with Chairman Tester and Ranking Member Moran to strengthen this legislat...